3.9 Article

Phenotypic Changes in Diabetic Neuropathy Induced by a High-Fat Diet in Diabetic C57Bl/6 Mice

Journal

EXPERIMENTAL DIABETES RESEARCH
Volume -, Issue -, Pages -

Publisher

HINDAWI LTD
DOI: 10.1155/2011/848307

Keywords

-

Funding

  1. Eunice Kennedy Shriver National Institute of Child Health & Human Development [T32HD057850]
  2. Juvenile Diabetes Research Foundation
  3. NIH [RO1NS43314]
  4. Kansas Intellectual and Developmental Disabilities Research Center [P30 NICHD HD 002528]
  5. NIH from the Idea Network of Biomedical Research Excellence (INBRE) of the National Center for Research Resources [P20 RR016475, R01NS43313]
  6. EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD057850, P30HD002528] Funding Source: NIH RePORTER
  7. NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER
  8. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043314] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Emerging evidence suggests that dyslipidemia is an independent risk factor for diabetic neuropathy (DN) (reviewed by Vincent et al. 2009). To experimentally determine how dyslipidemia alters DN, we quantified neuropathic symptoms in diabetic mice fed a high-fat diet. Streptozotocin-induced diabetic C57BL/6 mice fed a high-fat diet developed dyslipidemia and a painful neuropathy (mechanical allodynia) instead of the insensate neuropathy (mechanical insensitivity) that normally develops in this strain. Nondiabetic mice fed a high-fat diet also developed dyslipidemia and mechanical allodynia. Thermal sensitivity was significantly reduced in diabetic compared to nondiabetic mice, but was not worsened by the high-fat diet. Moreover, diabetic mice fed a high-fat diet had significantly slower sensory and motor nerve conduction velocities compared to nondiabetic mice. Overall, dyslipidemia resulting from a high-fat diet may modify DN phenotypes and/or increase risk for developing DN. These results provide new insight as to how dyslipidemia may alter the development and phenotype of diabetic neuropathy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available